1 study found for:    19852040 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C
Conditions: Hepatitis C;   Hepatitis
Interventions: Drug: Merimepodib;   Drug: PEG-Interferon-alpha 2a (Pegasys®);   Drug: Ribavirin (Copegus®)

Indicates status has not been verified in more than two years